(Q42207558)

English

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

scientific article published on 30 June 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective? (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

0 references

6

object named as

Karen Slobod

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

author name string

Gerry Oster

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

John Edelsberg

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Kalin Hennegan

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Clement Lewin

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Vas Narasimhan

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Morven S Edwards

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Carol J Baker

8

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

language of work or name

0 references

publication date

30 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

4778-4785

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Evaluation of Universal Antenatal Screening for Group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Placental transport of immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Comprehensive cost-utility analysis of newborn screening strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Health and economic implications of HPV vaccination in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Case records of the Massachusetts General Hospital. Case 27-2007. A 30-year-old pregnant woman with intrauterine fetal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Is antenatal syphilis screening still cost effective in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Antibiotics in the management of PROM and preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Association between colonization with Group B Streptococcus and preterm delivery: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.06.003

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.06.003

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42207558&oldid=1877493411"